MA24747A1 - Composition de mesylate de trovafloxacine et procede pour sa preparation - Google Patents

Composition de mesylate de trovafloxacine et procede pour sa preparation

Info

Publication number: MA24747A1
Authority: MA; Morocco
Prior art keywords: preparation; trovafloxacin mesylate; mesylate composition; composition; trovafloxacin
Prior art date: 1998-01-21

Application number

MA25433A

Other languages

English (en)

Inventor

Dale Johnson Alton

Michael Sinko Christopher

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-21

Filing date

1999-01-15

Publication date

1999-10-01

1999-01-15 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

1999-10-01 Publication of MA24747A1 publication Critical patent/MA24747A1/fr

Links

229960005021 trovafloxacin mesylate Drugs 0.000 title 1
DYNZICQDCVYXFW-AHZSKCOESA-N trovafloxacin mesylate Chemical compound CS(O)(=O)=O.C([C@H]1[C@@H]([C@H]1C1)N)N1C(C(=CC=1C(=O)C(C(O)=O)=C2)F)=NC=1N2C1=CC=C(F)C=C1F DYNZICQDCVYXFW-AHZSKCOESA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

MA25433A 1998-01-21 1999-01-15 Composition de mesylate de trovafloxacine et procede pour sa preparation MA24747A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US7201398P	1998-01-21	1998-01-21

Publications (1)

Publication Number	Publication Date
MA24747A1 true MA24747A1 (fr)	1999-10-01

Family

ID=22105016

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25433A MA24747A1 (fr)	1998-01-21	1999-01-15	Composition de mesylate de trovafloxacine et procede pour sa preparation

Country Status (34)

Country	Link
US (1)	US6187341B1 (fr)
EP (1)	EP0930068A3 (fr)
JP (1)	JPH11269072A (fr)
KR (1)	KR100314977B1 (fr)
CN (1)	CN1227743A (fr)
AP (1)	AP1094A (fr)
AR (1)	AR012780A1 (fr)
AU (1)	AU758381B2 (fr)
BG (1)	BG103106A (fr)
BR (1)	BR9900116A (fr)
CA (1)	CA2259698C (fr)
CO (1)	CO4810225A1 (fr)
DZ (1)	DZ2712A1 (fr)
EA (1)	EA003247B1 (fr)
GT (1)	GT199900004A (fr)
HR (1)	HRP990023A2 (fr)
HU (1)	HUP9900154A3 (fr)
ID (1)	ID23735A (fr)
IL (1)	IL128051A0 (fr)
IS (1)	IS4947A (fr)
MA (1)	MA24747A1 (fr)
NO (1)	NO990243L (fr)
NZ (1)	NZ333838A (fr)
OA (1)	OA10958A (fr)
PA (1)	PA8466701A1 (fr)
PE (1)	PE20000169A1 (fr)
PL (1)	PL330981A1 (fr)
SG (1)	SG70666A1 (fr)
SK (1)	SK4299A3 (fr)
TN (1)	TNSN99007A1 (fr)
TR (1)	TR199900089A3 (fr)
TW (1)	TW518224B (fr)
YU (1)	YU2399A (fr)
ZA (1)	ZA99393B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR9915208A (pt) *	1998-11-10	2001-07-31	Bayer Ag	Preparado farmacêutico de moxifloxacina
AU1188601A (en) *	1999-09-20	2001-04-24	Alza Corporation	Process for lessening polymorphic conversion of a drug
ECSP003699A (es) *	1999-10-08	2002-04-23	Smithkline Beecham Corp	Inhibidores de fab i
FR2808441B1 (fr) *	2000-05-04	2004-06-18	Oreal	Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) *	2000-06-26	2002-02-14	Bayer Ag	Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
DE60230934D1 (de) *	2001-04-06	2009-03-05	Affinium Pharm Inc	Fab-i-inhibitoren
EP1396263A1 (fr) *	2002-08-09	2004-03-10	Warner-Lambert Company	Compositions d'enrobage pour tablettes et caplets
EP1575951B1 (fr)	2002-12-06	2014-06-25	Debiopharm International SA	Composes heterocycliques, procedes de production de ceux-ci et utilisation de ceux-ci dans un traitement
CN100415284C (zh) *	2002-12-30	2008-09-03	毛友昌	六味木香片的制备方法
WO2004082586A2 (fr)	2003-03-17	2004-09-30	Affinium Pharmaceuticals, Inc.	Compositions comportant plusieurs agents antibiotiques, et leurs procedes de mise en oeuvre
EP1459739B1 (fr) *	2003-03-19	2008-01-02	The Jordanian Pharmaceutical Manufacturing Co. Ltd.	Compositions pharmaceutiques non-hygroscopique contenant des acides carboxiliques quinilones non-hydratés
US8906413B2 (en) *	2003-05-12	2014-12-09	Supernus Pharmaceuticals, Inc.	Drug formulations having reduced abuse potential
WO2005009395A2 (fr) *	2003-07-23	2005-02-03	L. Perrigo Company	Composition contenant des fibres cellulosiques
US8450307B2 (en)	2004-06-04	2013-05-28	Affinium Pharmaceuticals, Inc.	Therapeutic agents, and methods of making and using the same
WO2006044805A2 (fr) *	2004-10-15	2006-04-27	Supernus Pharmaceuticals, Inc.	Preparations pharmaceutiques pour lesquelles le risque d'abus est reduit
CA2632476A1 (fr) *	2005-12-05	2007-06-14	Affinium Pharmaceuticals, Inc.	Agents therapeutiques et ses procedes de fabrication et d'utilisation
EP2687533B1 (fr)	2006-07-20	2017-07-19	Debiopharm International SA	Dérivés d'acrylamide en tant qu'inhibiteurs de FAB I
WO2008098374A1 (fr) *	2007-02-16	2008-08-21	Affinium Pharmaceuticals, Inc.	Sels, promédicaments et polymorphes d'inhibiteurs de fab 1
KR101720885B1 (ko)	2012-06-19	2017-03-28	데비오팜 인터네셔날 에스 에이	(e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
RS61312B1 (sr)	2016-02-26	2021-02-26	Debiopharm Int Sa	Lek za lečenje infekcija dijabetskog stopala
MY203711A (en)	2019-02-14	2024-07-15	Debiopharm Int Sa	Afabicin formulation, method for making the same and uses thereof
JP7418475B2 (ja)	2019-06-14	2024-01-19	デバイオファームインターナショナルエス．エー．	バイオフィルムが関与する細菌感染症を治療するための医薬及びその使用
EP4580618A2 (fr) *	2022-08-30	2025-07-09	Pannex Therapeutics Inc.	Modulateurs de pannexine-1 et procédés de traitement de troubles dans lesquels la pannexine-1 est impliquée

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3601566A1 (de) *	1986-01-21	1987-07-23	Bayer Ag	Pharmazeutische zubereitungen von ciprofloxacin
US5286754A (en)	1986-01-21	1994-02-15	Bayer Aktiengesellschaft	Pharmaceutical formulations of ciprofloxacin
US4957554A (en)	1989-08-16	1990-09-18	Minnesota Mining And Manufacturing Company	Dimensionally-controlled ceramics
DE4120646A1 (de)	1991-06-22	1992-12-24	Bayer Ag	7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
PL325170A1 (en) *	1995-08-29	1998-07-06	Pfizer	Bipolar forms of throwaflocacin

1999
- 1999-01-11 PA PA19998466701A patent/PA8466701A1/es unknown
- 1999-01-13 EP EP99300258A patent/EP0930068A3/fr not_active Withdrawn
- 1999-01-14 TR TR1999/00089A patent/TR199900089A3/tr unknown
- 1999-01-14 SK SK42-99A patent/SK4299A3/sk unknown
- 1999-01-14 IL IL12805199A patent/IL128051A0/xx unknown
- 1999-01-14 AP APAP/P/1999/001443A patent/AP1094A/en active
- 1999-01-15 PE PE1999000036A patent/PE20000169A1/es not_active Application Discontinuation
- 1999-01-15 ID IDP990036D patent/ID23735A/id unknown
- 1999-01-15 OA OA9900009A patent/OA10958A/en unknown
- 1999-01-15 GT GT199900004A patent/GT199900004A/es unknown
- 1999-01-15 MA MA25433A patent/MA24747A1/fr unknown
- 1999-01-19 IS IS4947A patent/IS4947A/is unknown
- 1999-01-19 JP JP11010298A patent/JPH11269072A/ja active Pending
- 1999-01-19 AR ARP990100191A patent/AR012780A1/es not_active Application Discontinuation
- 1999-01-19 CA CA002259698A patent/CA2259698C/fr not_active Expired - Fee Related
- 1999-01-19 BR BR9900116-0A patent/BR9900116A/pt not_active IP Right Cessation
- 1999-01-20 NO NO990243A patent/NO990243L/no not_active Application Discontinuation
- 1999-01-20 NZ NZ333838A patent/NZ333838A/xx unknown
- 1999-01-20 DZ DZ990013A patent/DZ2712A1/fr active
- 1999-01-20 KR KR1019990001589A patent/KR100314977B1/ko not_active Expired - Fee Related
- 1999-01-20 US US09/233,823 patent/US6187341B1/en not_active Expired - Fee Related
- 1999-01-20 CN CN99101232A patent/CN1227743A/zh active Pending
- 1999-01-20 ZA ZA9900393A patent/ZA99393B/xx unknown
- 1999-01-20 YU YU2399A patent/YU2399A/sh unknown
- 1999-01-20 SG SG1999000117A patent/SG70666A1/en unknown
- 1999-01-20 AU AU12173/99A patent/AU758381B2/en not_active Ceased
- 1999-01-20 PL PL99330981A patent/PL330981A1/xx unknown
- 1999-01-20 TN TNTNSN99007A patent/TNSN99007A1/fr unknown
- 1999-01-20 HU HU9900154A patent/HUP9900154A3/hu unknown
- 1999-01-21 TW TW088100897A patent/TW518224B/zh not_active IP Right Cessation
- 1999-01-21 CO CO99003190A patent/CO4810225A1/es unknown
- 1999-01-21 EA EA199900046A patent/EA003247B1/ru not_active IP Right Cessation
- 1999-01-21 BG BG103106A patent/BG103106A/xx unknown
- 1999-01-21 HR HR60/072,013A patent/HRP990023A2/hr not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP0930068A3 (fr)	1999-12-22
TNSN99007A1 (fr)	2005-11-10
CN1227743A (zh)	1999-09-08
HRP990023A2 (en)	1999-08-31
DZ2712A1 (fr)	2003-09-01
HUP9900154A2 (hu)	1999-09-28
EP0930068A2 (fr)	1999-07-21
NO990243L (no)	1999-07-22
KR19990068014A (ko)	1999-08-25
KR100314977B1 (ko)	2001-11-24
SK4299A3 (en)	2000-06-12
EA199900046A2 (ru)	1999-08-26
CO4810225A1 (es)	1999-06-30
AR012780A1 (es)	2000-11-08
AP9901443A0 (en)	1999-03-31
SG70666A1 (en)	2000-02-22
AU1217399A (en)	1999-08-12
US6187341B1 (en)	2001-02-13
BR9900116A (pt)	2000-05-02
NZ333838A (en)	2000-03-27
EA199900046A3 (ru)	1999-12-29
CA2259698A1 (fr)	1999-07-21
TR199900089A2 (xx)	1999-10-21
GT199900004A (es)	2000-07-08
PE20000169A1 (es)	2000-03-10
NO990243D0 (no)	1999-01-20
JPH11269072A (ja)	1999-10-05
PL330981A1 (en)	1999-08-02
HUP9900154A3 (en)	2000-12-28
TW518224B (en)	2003-01-21
ZA99393B (en)	2000-07-21
AP1094A (en)	2002-08-19
EA003247B1 (ru)	2003-02-27
IS4947A (is)	1999-07-22
ID23735A (id)	2000-05-11
OA10958A (en)	2001-10-31
AU758381B2 (en)	2003-03-20
IL128051A0 (en)	1999-11-30
HU9900154D0 (en)	1999-03-29
BG103106A (en)	1999-08-31
PA8466701A1 (es)	2000-09-29
CA2259698C (fr)	2003-04-15
TR199900089A3 (tr)	1999-10-21
YU2399A (sh)	2002-06-19

Publication	Publication Date	Title
MA24747A1 (fr)	1999-10-01	Composition de mesylate de trovafloxacine et procede pour sa preparation
FR2795734B1 (fr)	2005-09-30	Conjugues d'erythropoietine,compositons les comprenant et procede pour leur preparation
MA25089A1 (fr)	2000-12-31	Formulations intranasales de mesylate de sildenafil et procede pour leur preparation
FR2773807B1 (fr)	2000-02-25	Materiau cellulaire souple, composition et procede pour sa preparation
EP1156324A4 (fr)	2007-03-21	Procede de differentiation d'echantillons
FR2780057B1 (fr)	2002-09-13	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
HUP0104582A3 (en)	2002-12-28	1,2-annelated quinoline derivatives, pharmaceutical compositions thereof, intermediates and process for their preparation
FR2752091B1 (fr)	1998-09-04	Composition pour electrode positive, procede de preparation
MA25223A1 (fr)	2001-07-02	Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine
MA26630A1 (fr)	2004-12-20	4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA25984A1 (fr)	2003-12-31	Procede pour preparation de maleate d'amlodipine.
FR2780728B1 (fr)	2001-02-16	Sel de paroxetine nouveau, procede pour sa preparation et compositions pharmaceutiques le contenant
EE04739B1 (et)	2006-12-15	Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ning vaheühend ja selle valmistamismeetod
EE200100574A (et)	2003-02-17	Uued ühendid, nende valmistamise meetod ning kasutamine
EP0938901A4 (fr)	2001-10-31	Compositions medicinales pour traiter les affections hepatiques
FR2781801B1 (fr)	2004-10-15	Procede pour la preparation de dianhydride pyromellique
EE04346B1 (et)	2004-08-16	Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
FR2818979B1 (fr)	2003-05-30	Procede de preparation d'imidaclopride
FR2773558B1 (fr)	2000-02-18	Procede pour l'obtention de 1-butene
EE200100573A (et)	2003-02-17	Uued ühendid, nende valmistamise meetod ning kasutamine
NO20004968L (no)	2000-12-01	Mastikblanding og fremgangsmåte til fremstilling derav
EP1071746A4 (fr)	2003-04-23	Procede de preparation de doxorubicine
MA26710A1 (fr)	2004-12-20	Formulations de doramectine antiparasitaires et procede pour leur preparation
HUP0104544A3 (en)	2003-12-29	New pharmaceutical composition and the process for its preparation
EE200000752A (et)	2002-04-15	Alfa-D-ksüloosiühendid, nende valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon